152 related articles for article (PubMed ID: 28113128)
1. N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy.
Teodori E; Dei S; Coronnello M; Floriddia E; Bartolucci G; Manetti D; Romanelli MN; Santo Domingo Porqueras D; Salerno M
Eur J Med Chem; 2017 Feb; 127():586-598. PubMed ID: 28113128
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters.
Dei S; Coronnello M; Floriddia E; Bartolucci G; Bellucci C; Guandalini L; Manetti D; Romanelli MN; Salerno M; Bello I; Mini E; Teodori E
Eur J Med Chem; 2014 Nov; 87():398-412. PubMed ID: 25282263
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
4. New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR).
Orlandi F; Coronnello M; Bellucci C; Dei S; Guandalini L; Manetti D; Martelli C; Romanelli MN; Scapecchi S; Salerno M; Menif H; Bello I; Mini E; Teodori E
Bioorg Med Chem; 2013 Jan; 21(2):456-65. PubMed ID: 23245571
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
Dei S; Coronnello M; Bartolucci G; Manetti D; Romanelli MN; Udomtanakunchai C; Salerno M; Teodori E
Eur J Med Chem; 2018 Mar; 147():7-20. PubMed ID: 29421572
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors.
Martelli C; Coronnello M; Dei S; Manetti D; Orlandi F; Scapecchi S; Novella Romanelli M; Salerno M; Mini E; Teodori E
J Med Chem; 2010 Feb; 53(4):1755-62. PubMed ID: 20104851
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of aminoester heterodimers containing flavone or chromone moieties as modulators of P-glycoprotein-based multidrug resistance (MDR).
Dei S; Romanelli MN; Manetti D; Chiaramonte N; Coronnello M; Salerno M; Teodori E
Bioorg Med Chem; 2018 Jan; 26(1):50-64. PubMed ID: 29162309
[TBL] [Abstract][Full Text] [Related]
8. Isomeric N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent P-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitors.
Teodori E; Martelli C; Salerno M; Darghal N; Dei S; Garnier-Suillerot A; Gualtieri F; Manetti D; Scapecchi S; Romanelli MN
J Med Chem; 2007 Feb; 50(4):599-602. PubMed ID: 17256837
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers.
Teodori E; Contino M; Riganti C; Bartolucci G; Braconi L; Manetti D; Romanelli MN; Trezza A; Athanasios A; Spiga O; Perrone MG; Giampietro R; Gazzano E; Salerno M; Colabufo NA; Dei S
Eur J Med Chem; 2019 Nov; 182():111655. PubMed ID: 31494468
[TBL] [Abstract][Full Text] [Related]
10. N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors.
Martelli C; Alderighi D; Coronnello M; Dei S; Frosini M; Le Bozec B; Manetti D; Neri A; Romanelli MN; Salerno M; Scapecchi S; Mini E; Sgaragli G; Teodori E
J Med Chem; 2009 Feb; 52(3):807-17. PubMed ID: 19140665
[TBL] [Abstract][Full Text] [Related]
11. Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells.
Teodori E; Braconi L; Bua S; Lapucci A; Bartolucci G; Manetti D; Romanelli MN; Dei S; Supuran CT; Coronnello M
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290281
[TBL] [Abstract][Full Text] [Related]
12. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S
Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy.
Martelli C; Dei S; Lambert C; Manetti D; Orlandi F; Romanelli MN; Scapecchi S; Salerno M; Teodori E
Bioorg Med Chem Lett; 2011 Jan; 21(1):106-9. PubMed ID: 21145739
[TBL] [Abstract][Full Text] [Related]
14. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
Ji BS; He L
J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
[TBL] [Abstract][Full Text] [Related]
15. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Ji BS; He L; Liu GQ
Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439
[TBL] [Abstract][Full Text] [Related]
17. Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation.
Chan KF; Wong IL; Kan JW; Yan CS; Chow LM; Chan TH
J Med Chem; 2012 Mar; 55(5):1999-2014. PubMed ID: 22320402
[TBL] [Abstract][Full Text] [Related]
18. Arylamino Esters As P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity.
Teodori E; Dei S; Floriddia E; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA
ChemMedChem; 2015 Aug; 10(8):1339-43. PubMed ID: 26012726
[TBL] [Abstract][Full Text] [Related]
19. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
20. Jatrophane diterpenoids from Euphorbia sororia as potent modulators against P-glycoprotein-based multidrug resistance.
Hu R; Gao J; Rozimamat R; Aisa HA
Eur J Med Chem; 2018 Feb; 146():157-170. PubMed ID: 29407947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
